Anika Therapeutics completes Parcus Medical acquisition

Anika Therapeutics on Jan. 24 acquired privately-held sports medicine company Parcus Medical.

Advertisement

Three insights:

1. Anika acquired all membership interests for $35 million with $60 million in potential incentives.

2. Parcus Medical’s product portfolio facilitates surgeries of the shoulder, knee, hip and distal extremities.

3. The acquisition grants Anika access to the ASC market, which may lead to new revenue streams.

More articles on devices:
Bundled payments in spine: 12 key thoughts for 2020
Should pain management physicians perform endoscopic spine surgery? 8 spine specialists discuss
Medtronic CEO Omar Ishrak becomes Intel board chairman: 4 details

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.